Swiss-based LimmaTech Biologics raises $37M
Zurich-based LimmaTech Biologics AG, a clinical-stage biopharmaceutical company, announced that it has secured $37M in a Series A round of funding. ...
Zurich-based LimmaTech Biologics AG, a clinical-stage biopharmaceutical company, announced that it has secured $37M in a Series A round of funding. ...